KMT2A and acute lymphoblastic leukemia: Adverse cytogenetics include, but, are not limited to, low hypodiploidy, KMT2A (previously MLL) translocations, t(8;14), complex karyotype (≥5 chromosomal abnormalities) and Ph-positive ALL.